Read more at CNBC.
FDA approval of Eli Lilly's Alzheimer's drug cements our decision not to take profits
Date: | |
Tag: | FDA |
Sort by
Filter
Date
-
CBS News - Top stories
FDA approves new treatment to slow progression of early Alzheimer's
The FDA approved a new Alzheimer's treatment called donanemab on Tuesday. It is designed to help patients in the early stages of the disease. CBS News chief medical correspondent Dr. Jon LaPook explains what to know.FDA -
CNBC - Business
We're taking profits in this beer maker and buying more of our newest stock
We will realize a double-digit gain on the sale and pour half of it into our latest addition to the portfolio. -
CNBC - Business
Wall Street firm gets it right with Best Buy call, plus Eli Lilly shares move up
The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET. -
The Hill - Politics
Is our food supply chain at risk?
Any disruptions along the food supply chain can have disastrous consequences. -
BBC News - Top stories
Study links weight-loss drug to rare eye condition
People prescribed semaglutide may have a higher risk of developing a rare eye condition, a study suggests. -
CBS News - Top stories
FDA bans ingredient found in some citrus-flavored sodas
Brominated vegetable oil will no longer be allowed in food and beverages in the U.S., 50 years after chemical banned in U.K.FDA -
CBS News - Top stories
Many tattoo ink and permanent makeup products contaminated, FDA finds
The FDA found even some products that claimed to be "sterile" were contaminated. -
CNBC - Business
Constellation delivers beer profits, but weakness in wine prompts a downgrade
We want to see actual progress in wines and spirits before getting more positive on the trajectory of the stock. -
The New York Times - Health
V. Craig Jordan, Who Discovered a Key Breast Cancer Drug, Dies at 76
He found that a failed contraceptive, tamoxifen, could block the growth of cancer cells, opening up a whole new class of treatment. -
MarketWatch - Business
Constellation Brands profit tops estimates and company backs guidance, offsetting slight sales miss
The brewer of Modelo Especial is still expecting sales to grow 6% to 7% in fiscal 2025.
More from CNBC
-
CNBC - Business
Fed says it's not ready to cut rates until 'greater confidence' inflation is moving to 2% goal
The Federal Reserve on Wednesday released minutes from its June 11-12 meeting.Federal Reserve -
CNBC - Business
Vice President Kamala Harris' past donors privately strategize in case Biden drops out
Vice President Kamala Harris' allies discuss scenarios in the event that President Joe Biden decides not to keep his reelection campaign going.Joe Biden -
CNBC - Business
Southwest Airlines adopts 'poison pill' to fend off activist Elliott Management
Southwest adopted a shareholder rights plan to fend off an effort from activist Elliott Management to oust CEO Bob Jordan and Chairman Gary Kelly. -
CNBC - Business
Biden tries to calm Democrats as 2024 drop-out pressure mounts: 'I'm not leaving'
President Biden delivered a stumbling debate performance against Donald Trump last week, which his campaign has worked to spin in the ensuing days.Joe Biden -
CNBC - Business
Biden tells ally he's weighing whether to stay in the race: Reports
The reported conversation with the ally came amid the fallout from Biden's devastating presidential debate with Trump.Joe Biden